April 2024 Federal Circuit Newsletter (Japanese) April 2024 Federal Circuit Newsletter (Chinese) Obviousness Analysis Does Not Consider Unclaimed Limitations In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals Usa, Inc., Appeal No….
In the latest installment of Knobbe Martens’ monthly column focused on recent noteworthy Federal Circuit decisions, partners Sean Murray and Jeremiah Helm examine the outcome of Salix Pharmaceuticals v. Norwich Pharmaceuticals….
In the article “Prior Art Problems: Counsel Mull AI-Generated Disclosures,” partner Mauricio Uribe offered insight on the recent Request for Comment (RFC) from the US Patent and Trademark Office (USPTO),…
In the Chemical Processing article “Non-Compete-Ban Best Practices For The Chemical Industry,” partner Joseph Reisman commented on the recently promulgated Federal Trade Commission (FTC) final rule banning noncompete agreements and,…
IRVINE, Calif., April 30, 2024 – Knobbe Martens, a leading intellectual property law firm, is excited to announce the launch of its new podcast series, “Knobbe IP+“. The podcast provides…
IRVINE, CALIF., April 29, 2024 – Knobbe Martens is pleased to announce that the firm was named Firm of the Year: Patent Disputes (West) at the 2024 Managing IP Americas Awards, held…
WASHINGTON, D.C., April 23, 2024 – Knobbe Martens congratulates partner William Zimmerman and associates Justin Culbertson and Christopher Lewis on being recognized by Washington, D.C. Super Lawyers. Mr. Zimmerman was…
In the World Trademark Review article “Navigating Deepfake Risks: Age Old Problems, Brand New Tech,” Jonathan Hyman, co-chair of the firm’s advertising, media and entertainment practice group, shared practical ways…
In the IPWatchdog article “Young Sheldon’s Inventorship Woes: Important Lessons for All Young Inventors,” associate Matt Pham and partner Baraa Kahf offer advice for young inventors who are looking to…
In the Bloomberg Law article “Patent AI Notice Spurs Concerns of Dueling Disclosure Priorities,” Knobbe Martens partner Mauricio Uribe provided additional commentary and analysis of how the US Patent and…
